Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06903676 · ClinicalTrials.gov registry record · NA
Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
A NA study of Pancreatitis and Pancreatectomy, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT06903676: Recruiting NA study of Pancreatitis and Pancreatectomy, sponsored by Indiana University.
NCT06903676 is a NA study of Pancreatitis and Pancreatectomy that is actively recruiting participants, run by Indiana University. The registered enrollment target is 50 participants, below the 619-participant average among 17 other Pancreatitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06903676, a NA study of Pancreatitis and Pancreatectomy, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.
Primary Outcome
TRP-2 will be measured in freshly obtained urine preoperatively as a control, intraoperatively at time of pancreas transection, in the post anesthesia recovery unit, and in the morning of POD 1-3. This will be measured by the Actim Pancreatitis urine dipstick test. This will be compared to standard of care serum amylase tests.
Conditions Studied
Interventions
- DEVICE TRP-2 Urine Dipstick
Study Locations (1)
Indiana
- Indiana University Health University Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-04 |
| Phase | NA |
What NCT06903676 shows while recruiting
NCT06903676 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 619-participant average among 17 other Pancreatitis trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Pancreatitis appearing as the primary indexed condition, and to 1 intervention - of which TRP-2 Urine Dipstick is the first listed.
NCT06903676 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT06903676 about?
NCT06903676 is a clinical study titled "Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)". The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.
What is the current status of trial NCT06903676?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-05. Estimated completion is 2026-04.
What conditions does trial NCT06903676 study?
This clinical trial studies the following conditions: Pancreatitis, Pancreatectomy.
What interventions are being tested in trial NCT06903676?
The interventions under investigation include: TRP-2 Urine Dipstick (DEVICE).
Who is sponsoring clinical trial NCT06903676?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06903676 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06903676's enrollment target sits among peer trials
50 16th of 17 higher than 2 of 17 other Pancreatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
RECRUITING · NA
-
Scrambler Therapy in Chronic Pancreatitis
RECRUITING · NA
-
Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
RECRUITING · NA
-
Digital Exercise for Middle-Aged Adults With Type 1 Diabetes and Other Absolute Insulin Deficiency Diabetes
COMPLETED · NA
-
Pancreas Resection With and Without Drains
COMPLETED · NA
-
SpHincterotomy for Acute Recurrent Pancreatitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI